Literature DB >> 25439384

Idiopathic nonhistaminergic angioedema successfully treated with ecallantide, icatibant, and C1 esterase inhibitor replacement.

Mark C Stahl1, Caitlin K Harris2, Sulaiman Matto2, Jonathan A Bernstein3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25439384     DOI： 10.1016/j.jaip.2014.05.006

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  5 in total

Review 1.  Multifunctional roles of leader protein of foot-and-mouth disease viruses in suppressing host antiviral responses.

Authors:  Yingqi Liu; Zixiang Zhu; Miaotao Zhang; Haixue Zheng
Journal:  Vet Res       Date:  2015-10-28       Impact factor: 3.683

2.  Angioedema suppressed by a combination of anti-histamine and leukotriene modifier.

Authors:  Brendan N Wong; Peter Vadas
Journal:  Allergy Asthma Clin Immunol       Date:  2017-06-13       Impact factor: 3.406

3.  Idiopathic non-histaminergic acquired angioedema: a case series and discussion of published clinical trials.

Authors:  Martin Christian Bucher; Tatjana Petkovic; Arthur Helbling; Urs Christian Steiner
Journal:  Clin Transl Allergy       Date:  2017-08-31       Impact factor: 5.871

Review 4.  Efficacy of Treatment of Non-hereditary Angioedema.

Authors:  Mignon van den Elzen; M F C L Go; A C Knulst; M A Blankestijn; H van Os-Medendorp; H G Otten
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

5.  Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients.

Authors:  Enrico Brunetta; Dana Shiffer; Marco Folci; Maria I S Achenza; Francesca Puggioni; Enrico Heffler; Raffaello Furlan; Giorgio W Canonica
Journal:  Case Reports Immunol       Date:  2018-07-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.